How wide is the spectrum of neuroendocrine carcinoma of the urinary bladder?

American Journal of Clinical Pathology

Volumn 128, Issue 5, 2007, Pages 723-725

  Vakar Lopez, Funda ^a   True, Lawrence D ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD57 ANTIGEN; CHROMOGRANIN; SYNAPTOPHYSIN; THYROID TRANSCRIPTION FACTOR 1;

BLADDER CARCINOMA; CYTOLOGY; EDITORIAL; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOPATHOLOGY; LARGE CELL CARCINOMA; NEUROENDOCRINE TUMOR; PHENOTYPE; PRIORITY JOURNAL;

CARCINOMA, NEUROENDOCRINE; CHROMOGRANINS; DIAGNOSIS, DIFFERENTIAL; HUMANS; SYNAPTOPHYSIN; TUMOR MARKERS, BIOLOGICAL; URINARY BLADDER NEOPLASMS;

EID: 36249022180     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/N5N5Y8VD90W91WQP     Document Type: Editorial

References (14)

1. Grignon DJ, Ro JY, Ayala AG, et al. Small cell carcinoma of the urinary bladder: a clinicopathologic analysis of 22 cases. Cancer. 1992;69:527-536.
2. Bex A, Nieuwenhuijzen JA, Kerst M, et al. Small cell carcinoma of bladder: a single-center prospective study of 25 cases treated in analogy to small cell lung cancer. Urology. 2005;65:295-299.
3. Travis WD, Linnoila RI, Tsokos MG, et al. Neuroendocrine tumors of the lung with proposed criteria for large-cell neuroendocrine carcinoma: an ultrastructural, immunohistochemical, and flow cytometric study of 35 cases. Am J Surg Pathol. 1991;15:529-553.
4. Alijo Serrano F, Sánchez-Mora N, Arranz JA, et al. Large cell and small cell neuroendocrine bladder carcinoma: immunohistochemical and outcome study in a single institution. Am J Clin Pathol. 2007;128:733-739.
5. Pan CX, Zhang H, Lara PN Jr, et al. Small-cell carcinoma of the urinary bladder: diagnosis and management. Expert Rev Anticancer Ther. 2006;6:1707-1713.
6. Travis WD, Gal AA, Colby TV, et al. Reproducibility of neuroendocrine lung tumor classification. Hum Pathol. 1998;29:272-279.
7. Agoff SN, Lamps LW, Philip AT, et al. Thyroid transcription factor-1 is expressed in extrapulmonary small cell carcinomas but not in other extrapulmonary neuroendocrine tumors. Mod Pathol. 2000;13:238-242.
8. Seshi B, True L, Carter D, et al. Immunohistochemical characterization of a set of monoclonal antibodies to human neuron-specific enolase. Am J Pathol. 1988;131:258-269.
9. di Sant'Agnese PA. Neuroendocrine differentiation in prostatic carcinoma: an update. Prostate Suppl. 1998;8:74-79.
10. Abrahamsson PA. Neuroendocrine cells in tumour growth of the prostate. Endocr Relat Cancer. 1999;6:503-519.
11. Lee KH, Ryu SB, Lee MC, et al. Primary large cell neuroendocrine carcinoma of the urinary bladder. Pathol Int. 2006;56:688-693.
12. Clegg N, Ferguson C, True LD, et al. Molecular characterization of prostatic small-cell neuroendocrine carcinoma. Prostate. 2003;55:55-64.
13. Difilippantonio S, Chen Y, Pietas A, et al. Gene expression profiles in human non-small and small-cell lung cancers. Eur J Cancer. 2003;39:1936-1947.
14. Takata R, Katagiri T, Kanehira M, et al. Validation study of the prediction system for clinical response of M-VAC neoadjuvant chemotherapy. Cancer Sci. 2007;98:113-117.